Financials

  • Market Capitalization 7.95 M
  • Employee 6
  • Founded 2016
  • CEO N/A
  • Website www.alzamend.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZMXG7M8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.43
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4815
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-7.32%+2.70%-66.37%8.27 M USD
4818
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.52 USD0.00%-3.16%+14.76%-10.97%8.07 M USD
4824
AIM
AIM ImmunoTech Inc. Common Stock
0.26 USD+4.00%0.00%+8.33%-89.65%7.91 M USD
4825
SKYE
Skye Bioscience, Inc. - Common Stock
1.78 USD-8.72%-21.24%+212.28%+122.50%7.88 M USD

Frequently asked questions about Alzamend Neuro, Inc. Common Stock

What is the Alzamend Neuro, Inc. Common Stock stock price today?

The current price of Alzamend Neuro, Inc. Common Stock (ALZN) is 1.66. Over the past 24 hours, the stock has changed by -0.60%. Follow the ALZN chart for real-time price dynamics.

What is the stock ticker of Alzamend Neuro, Inc. Common Stock?

Alzamend Neuro, Inc. Common Stock trades under the ticker ALZN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Alzamend Neuro, Inc. Common Stock stock going up?

ALZN has changed by +9.93% over the last week, +22.06% over the last month, and -32.52% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Alzamend Neuro, Inc. Common Stock?

Alzamend Neuro, Inc. Common Stock currently has a market capitalization of 7.95 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Alzamend Neuro, Inc. Common Stock earnings last quarter?

Last quarter, Alzamend Neuro, Inc. Common Stock reported earnings of -0.47 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Alzamend Neuro, Inc. Common Stock net income for the last quarter?

Alzamend Neuro, Inc. Common Stock reported net income of -2.87 M for the last quarter. The previous quarter showed -2.2 M, which means net income changed by -30.51%.

How many employees does Alzamend Neuro, Inc. Common Stock have?

As of the latest available data, Alzamend Neuro, Inc. Common Stock has 6 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Alzamend Neuro, Inc. Common Stock stock?

You can buy Alzamend Neuro, Inc. Common Stock (ALZN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Alzamend Neuro, Inc. Common Stock stock?

Investing in Alzamend Neuro, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALZN chart and related analysis on metatrader.com as part of your research.

News